Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Journal for Immunotherapy of Cancer
|
March 22, 2024
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells
Maxim Yankelevich, Archana Thakur, Shakeel Modak, et al.
Transplantation and Cellular Therapy
|
May 14, 2026
Chimeric Antigen Receptor T-Cell Therapy in Autoimmune Disorders: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
Olalekan O Oluwole, Leslie Crofford, Andrew P Jallouk, et al.
Blood Advances
|
August 8, 2022
The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes
Aiman J Faruqi, John A Ligon, Paul Borgman, et al.
Blood
|
December 18, 2012
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
Waleed Haso, Daniel W Lee, Nirali N Shah, et al.
Blood Advances
|
December 17, 2021
Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy
Elizabeth M Holland, Bonnie Yates, Alex Ling, et al.
Haematologica
|
February 9, 2018
Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma
Haneen Shalabi, Ira L Kraft, Hao-Wei Wang, et al.
Neuro-Oncology
|
February 11, 2022
Neurotoxicity following CD19/CD28ζ CAR T-cells in children and young adults with B-cell malignancies
Haneen Shalabi, Staci Martin, Bonnie Yates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2021
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL
Nirali N Shah, Daniel W Lee, Bonnie Yates, et al.
Blood Advances
|
October 7, 2021
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days
Lekha Mikkilineni, Bonnie Yates, Seth M Steinberg, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2022
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation
Elizabeth M Holland, John C Molina, Kniya Dede, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Journal for Immunotherapy of Cancer
|
March 22, 2024
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells
Maxim Yankelevich, Archana Thakur, Shakeel Modak, et al.
Transplantation and Cellular Therapy
|
May 14, 2026
Chimeric Antigen Receptor T-Cell Therapy in Autoimmune Disorders: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
Olalekan O Oluwole, Leslie Crofford, Andrew P Jallouk, et al.
Blood Advances
|
August 8, 2022
The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes
Aiman J Faruqi, John A Ligon, Paul Borgman, et al.
Blood
|
December 18, 2012
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
Waleed Haso, Daniel W Lee, Nirali N Shah, et al.
Blood Advances
|
December 17, 2021
Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy
Elizabeth M Holland, Bonnie Yates, Alex Ling, et al.
Haematologica
|
February 9, 2018
Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma
Haneen Shalabi, Ira L Kraft, Hao-Wei Wang, et al.
Neuro-Oncology
|
February 11, 2022
Neurotoxicity following CD19/CD28ζ CAR T-cells in children and young adults with B-cell malignancies
Haneen Shalabi, Staci Martin, Bonnie Yates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2021
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL
Nirali N Shah, Daniel W Lee, Bonnie Yates, et al.
Blood Advances
|
October 7, 2021
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days
Lekha Mikkilineni, Bonnie Yates, Seth M Steinberg, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2022
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation
Elizabeth M Holland, John C Molina, Kniya Dede, et al.
Page
of 6